TABLE OF CONTENTS
1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.3 OVERVIEW OF GLOBAL DERMAL FILLERS MARKET 36
1.4 LIMITATIONS 38
1.5 MARKETS COVERED 38
2 MARKET SEGMENTATION 43
2.1 MARKETS COVERED 43
2.2 GEOGRAPHICAL SCOPE 44
2.3 YEARS CONSIDERED FOR THE STUDY 45
2.4 CURRENCY AND PRICING 45
2.5 DBMR TRIPOD DATA VALIDATION MODEL 46
2.6 MULTIVARIATE MODELLING 49
2.7 PRODUCTS LIFELINE CURVE 49
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 50
2.9 DBMR MARKET POSITION GRID 51
2.10 VENDOR SHARE ANALYSIS 52
2.11 SECONDARY SOURCES 53
2.12 ASSUMPTIONS 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 58
5 MARKET OVERVIEW 60
5.1 DRIVERS 62
5.1.1 RISING DEMAND FOR ANTI-AGING THERAPEUTICS 62
5.1.2 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES 65
5.1.3 INCREASING NUMBER OF FACIAL VOLUME REPLACEMENT AND ENHANCEMENT PROCEDURES 68
5.1.4 INCREASING PREVALENCE OF FACIAL SOFT TISSUE DISEASE AND DISORDERS 69
5.1.5 GROWING AWARENESS FOR THE COSMETIC PROCEDURES 70
5.2 RESTRAINTS 72
5.2.1 STRINGENT REGULATION, GUIDELINES, STANDARDS FOR DERMAL FILLERS 72
5.2.2 HIGH COST OF PROCEDURES 74
5.3 OPPORTUNITIES 75
5.3.1 ADVANCEMENT IN THE DERMAL FILLERS 75
5.3.2 GROWING COSMETIC EXPENDITURE 76
5.3.3 RISING ACCIDENT CLAIMS FOR DERMAL FILLER INJURIES 77
5.4 CHALLENGES 78
5.4.1 INCREASING SIDE EFFECTS OF THE DERMAL FILLER 78
5.4.2 AVAILABILITY OF ALTERNATIVES 79
6 GLOBAL DERMAL FILLERS MARKET, BY TYPE 80
6.1 OVERVIEW 81
6.2 SEMI-PERMANENT DERMAL FILLER 83
6.3 PERMANENT DERMAL FILLER 84
7 GLOBAL DERMAL FILLERS MARKET, BY PRODUCT TYPE 85
7.1 OVERVIEW 86
7.2 BIODEGRADABLE DERMAL FILLERS 88
7.3 NON-BIODEGRADABLE DERMAL FILLERS 89
8 GLOBAL DERMAL FILLERS MARKET, BY APPLICATION 90
8.1 OVERVIEW 91
8.2 FACIAL LINE CORRECTION 94
8.3 WRINKLES 94
8.4 LIP ENHANCEMENT 95
8.5 FACE LIFT 95
8.6 RHINOPLASTY 96
8.7 SCAR TREATMENT 96
8.8 SAGGING SKIN 97
8.9 CHEEK DEPRESSION 97
8.10 DENTISTRY 98
8.11 RECONSTRUCTIVE SURGERY 98
8.12 AESTHETIC RESTORATION 99
8.13 OTHERS 99
9 GLOBAL DERMAL FILLERS MARKET, BY MATERIAL TYPE 100
9.1 OVERVIEW 101
9.2 NATURAL DERMAL FILLERS 103
9.2.1 HYALURONIC ACID 104
9.2.1.1 BY MATERIAL TYPE 104
9.2.1.1.1 SINGLE-PHASE 104
9.2.1.1.2 DUPLEX-PHASE 104
9.2.1.2 BY APPLICATION 105
9.2.1.2.1 FACIAL LINE CORRECTION 105
9.2.1.2.2 WRINKLES 105
9.2.1.2.3 LIP ENHANCEMENT 105
9.2.1.2.4 FACE LIFT 106
9.2.1.2.5 RHINOPLASTY 106
9.2.1.2.6 SCAR TREATMENT 106
9.2.1.2.7 SAGGING SKIN 106
9.2.1.2.8 CHEEK DEPRESSION 106
9.2.1.2.9 DENTISTRY 106
9.2.1.2.10 RECONSTRUCTIVE SURGERY 106
9.2.1.2.11 AESTHETIC RESTORATION 106
9.2.1.2.12 OTHERS 107
9.2.2 FAT 107
9.2.2.1 BY APPLICATION 107
9.2.2.1.1 FACIAL LINE CORRECTION 107
9.2.2.1.2 WRINKLES 107
9.2.2.1.3 LIP ENHANCEMENT 108
9.2.2.1.4 FACE LIFT 108
9.2.2.1.5 RHINOPLASTY 108
9.2.2.1.6 SCAR TREATMENT 108
9.2.2.1.7 SAGGING SKIN 108
9.2.2.1.8 CHEEK DEPRESSION 108
9.2.2.1.9 DENTISTRY 108
9.2.2.1.10 RECONSTRUCTIVE SURGERY 108
9.2.2.1.11 AESTHETIC RESTORATION 108
9.2.2.1.12 OTHERS 109
9.2.3 COLLAGEN 109
9.2.3.1 BY APPLICATION 109
9.2.3.1.1 FACIAL LINE CORRECTION 109
9.2.3.1.2 WRINKLES 109
9.2.3.1.3 LIP ENHANCEMENT 110
9.2.3.1.4 FACE LIFT 110
9.2.3.1.5 RHINOPLASTY 110
9.2.3.1.6 SCAR TREATMENT 110
9.2.3.1.7 SAGGING SKIN 110
9.2.3.1.8 CHEEK DEPRESSION 110
9.2.3.1.9 DENTISTRY 110
9.2.3.1.10 RECONSTRUCTIVE SURGERY 110
9.2.3.1.11 AESTHETIC RESTORATION 111
9.2.3.1.12 OTHERS 111
?
9.2.4 OTHERS 111
9.2.4.1 BY APPLICATION 111
9.2.4.1.1 FACIAL LINE CORRECTION 111
9.2.4.1.2 WRINKLES 112
9.2.4.1.3 LIP ENHANCEMENT 112
9.2.4.1.4 FACE LIFT 112
9.2.4.1.5 RHINOPLASTY 112
9.2.4.1.6 SCAR TREATMENT 112
9.2.4.1.7 SAGGING SKIN 112
9.2.4.1.8 CHEEK DEPRESSION 112
9.2.4.1.9 DENTISTRY 112
9.2.4.1.10 RECONSTRUCTIVE SURGERY 113
9.2.4.1.11 AESTHETIC RESTORATION 113
9.2.4.1.12 OTHERS 113
9.3 SYNTHETIC DERMAL FILLERS 113
9.3.1 POLY-L-LACTIC ACID 114
9.3.1.1 BY APPLICATION 114
9.3.1.1.1 FACIAL LINE CORRECTION 114
9.3.1.1.2 WRINKLES 114
9.3.1.1.3 LIP ENHANCEMENT 115
9.3.1.1.4 FACE LIFT 115
9.3.1.1.5 RHINOPLASTY 115
9.3.1.1.6 SCAR TREATMENT 115
9.3.1.1.7 SAGGING SKIN 115
9.3.1.1.8 CHEEK DEPRESSION 115
9.3.1.1.9 DENTISTRY 115
9.3.1.1.10 RECONSTRUCTIVE SURGERY 115
9.3.1.1.11 AESTHETIC RESTORATION 116
9.3.1.1.12 OTHERS 116
9.3.2 CALCIUM HYDROXYLAPATITE 116
9.3.2.1 BY APPLICATION 116
9.3.2.1.1 FACIAL LINE CORRECTION 116
9.3.2.1.2 WRINKLES 117
9.3.2.1.3 LIP ENHANCEMENT 117
9.3.2.1.4 FACE LIFT 117
9.3.2.1.5 RHINOPLASTY 117
9.3.2.1.6 SCAR TREATMENT 117
9.3.2.1.7 SAGGING SKIN 117
9.3.2.1.8 CHEEK DEPRESSION 117
9.3.2.1.9 DENTISTRY 117
9.3.2.1.10 RECONSTRUCTIVE SURGERY 118
9.3.2.1.11 AESTHETIC RESTORATION 118
9.3.2.1.12 OTHERS 118
9.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) 118
9.3.3.1 BY APPLICATION 118
9.3.3.1.1 FACIAL LINE CORRECTION 119
9.3.3.1.2 WRINKLES 119
9.3.3.1.3 LIP ENHANCEMENT 119
9.3.3.1.4 FACE LIFT 119
9.3.3.1.5 RHINOPLASTY 119
9.3.3.1.6 SCAR TREATMENT 119
9.3.3.1.7 SAGGING SKIN 119
9.3.3.1.8 CHEEK DEPRESSION 119
9.3.3.1.9 DENTISTRY 120
9.3.3.1.10 RECONSTRUCTIVE SURGERY 120
9.3.3.1.11 AESTHETIC RESTORATION 120
9.3.3.1.12 OTHERS 120
9.3.4 POLYALKYLIMIDE 120
9.3.4.1 BY APPLICATION 120
9.3.4.1.1 FACIAL LINE CORRECTION 121
9.3.4.1.2 WRINKLES 121
9.3.4.1.3 LIP ENHANCEMENT 121
9.3.4.1.4 FACE LIFT 121
9.3.4.1.5 RHINOPLASTY 121
9.3.4.1.6 SCAR TREATMENT 121
9.3.4.1.7 SAGGING SKIN 121
9.3.4.1.8 CHEEK DEPRESSION 121
9.3.4.1.9 DENTISTRY 122
9.3.4.1.10 RECONSTRUCTIVE SURGERY 122
9.3.4.1.11 AESTHETIC RESTORATION 122
9.3.4.1.12 OTHERS 122
9.3.5 OTHERS 123
9.3.5.1 BY APPLICATION 123
9.3.5.1.1 FACIAL LINE CORRECTION 123
9.3.5.1.2 WRINKLES 123
9.3.5.1.3 LIP ENHANCEMENT 123
9.3.5.1.4 Face Lift 124
9.3.5.1.5 RHINOPLASTY 124
9.3.5.1.6 SCAR TREATMENT 124
9.3.5.1.7 SAGGING SKIN 124
9.3.5.1.8 CHEEK DEPRESSION 124
9.3.5.1.9 DENTISTRY 124
9.3.5.1.10 RECONSTRUCTIVE SURGERY 124
9.3.5.1.11 AESTHETIC RESTORATION 124
9.3.5.1.12 OTHERS 125
10 GLOBAL DERMAL FILLERS MARKET, BY DRUG TYPE 126
10.1 OVERVIEW 127
10.2 BRANDED 129
10.2.1 JUVEDERM 129
10.2.2 SCULPTRA 129
10.2.3 RADIESSE 130
10.2.4 RESTYLANE 130
10.2.5 BELLAFILL 130
10.2.6 PURAGEN 130
10.2.7 ELEVESS 130
10.2.8 AQUAMID 130
10.2.9 OTHERS 130
10.3 GENERIC 130
11 GLOBAL DERMAL FILLERS MARKET, BY END USER 131
11.1 OVERVIEW 132
11.2 DERMATOLOGY CLINICS 135
11.3 AMBULATORY SURGICAL CENTERS 135
11.4 HOSPITALS 136
11.5 OTHERS 136
12 GLOBAL DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL 137
12.1 OVERVIEW 138
12.2 DRUG STORES 140
12.3 RETAIL PHARMACY 140
12.4 ONLINE PHARMACIES 141
13 GLOBAL DERMAL FILLER MARKET, BY GEOGRAPHY 142
13.1 OVERVIEW 143
13.2 NORTH AMERICA 148
13.2.1 U.S. 160
13.2.2 MEXICO 168
13.2.3 CANADA 177
?
13.3 ASIA-PACIFIC 186
13.3.1 JAPAN 198
13.3.2 AUSTRALIA 207
13.3.3 SOUTH KOREA 216
13.3.4 CHINA 225
13.3.5 INDIA 234
13.3.6 THAILAND 243
13.3.7 SINGAPORE 252
13.3.8 MALAYSIA 261
13.3.9 INDONESIA 270
13.3.10 PHILIPPINES 279
13.3.11 REST OF ASIA-PACIFIC 288
13.4 SOUTH AMERICA 289
13.4.1 BRAZIL 301
13.4.2 REST OF SOUTH AMERICA 310
13.5 MIDDLE EAST AND AFRICA 311
13.5.1 SOUTH AFRICA 323
13.5.2 REST OF MIDDLE EAST AND AFRICA 332
14 GLOBAL DERMAL FILLERS MARKET, COMPANY LANDSCAPE 333
14.1 COMPANY SHARE ANALYSIS: GLOBAL 333
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 334
14.3 COMPANY SHARE ANALYSIS: EUROPE 335
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 336
15 COMPANY PROFILE 337
15.1 ALLERGAN 337
15.1.1 COMPANY SNAPSHOT 337
15.1.2 REVENUE ANALYSIS 338
15.1.3 COMPANY SHARE ANALYSIS 338
15.1.4 PRODUCT PORTFOLIO 338
15.1.5 RECENT DEVELOPMENTS 339
15.2 GALDERMA LABORATORIES, L.P. 340
15.2.1 COMPANY SNAPSHOT 340
15.2.2 COMPANY SHARE ANALYSIS 340
15.2.3 BRAND PORTFOLIO 340
15.2.4 RECENT DEVELOPMENTS 341
15.3 MERZ PHARMA 342
15.3.1 COMPANY SNAPSHOT 342
15.3.2 COMPANY SHARE ANALYSIS 342
15.3.3 PRODUCT PORTFOLIO 342
15.3.4 RECENT DEVELOPMENTS 343
15.4 ANIKA THERAPEUTICS, INC. 344
15.4.1 COMPANY SNAPSHOT 344
15.4.2 REVENUE ANALYSIS 344
15.4.3 PRODUCT PORTFOLIO 345
15.4.4 RECENT DEVELOPMENT 345
15.5 BIOHA LABORATORIES 346
15.5.1 COMPANY SNAPSHOT 346
15.5.2 PRODUCT PORTFOLIO 346
15.5.3 RECENT DEVELOPMENTS 347
15.6 BIOPLUS CO., LTD. 348
15.6.1 COMPANY SNAPSHOT 348
15.6.2 PRODUCT PORTFOLIO 348
15.6.3 RECENT DEVELOPMENTS 348
15.7 BIOXIS PHARMACEUTICALS 349
15.7.1 COMPANY SNAPSHOT 349
15.7.2 PRODUCT PORTFOLIO 349
15.7.3 RECENT DEVELOPMENT 349
15.8 CONTURA LTD. 350
15.8.1 COMPANY SNAPSHOT 350
15.8.2 PRODUCT PORTFOLIO 350
15.8.3 RECENT DEVELOPMENT 350
15.9 CROMA-PHARMA GMBH 351
15.9.1 COMPANY SNAPSHOT 351
15.9.2 PRODUCT PORTFOLIO 351
15.9.3 RECENT DEVELOPMENTS 351
15.10 HUMEDIX.CO.LTD (A SUBSIDIARY OF HUONS GLOBAL) 352
15.10.1 COMPANY SNAPSHOT 352
15.10.2 PRODUCT PORTFOLIO 352
15.10.3 RECENT DEVELOPMENT 352
15.11 PROLLENIUM MEDICAL TECHNOLOGIES 353
15.11.1 COMPANY SNAPSHOT 353
15.11.2 BRAND PORTFOLIO 353
15.11.3 RECENT DEVELOPMENT 353
15.12 SCULPT LUXURY DERMAL FILLERS LTD 354
15.12.1 COMPANY SNAPSHOT 354
15.12.2 PRODUCT PORTFOLIO 354
15.12.3 RECENT DEVELOPMENT 354
?
15.13 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE CO., LTD.) 355
15.13.1 COMPANY SNAPSHOT 355
15.13.2 PRODUCT PORTFOLIO 355
15.13.3 RECENT DEVELOPMENT 355
15.14 SUNEVA MEDICAL 356
15.14.1 COMPANY SNAPSHOT 356
15.14.2 PRODUCT PORTFOLIO 356
15.14.3 RECENT DEVELOPMENTS 356
15.15 TEOXANE 357
15.15.1 COMPANY SNAPSHOT 357
15.15.2 PRODUCT PORTFOLIO 357
15.15.3 RECENT DEVELOPMENT 357
15.16 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO.,LTD. 358
15.16.1 COMPANY SNAPSHOT 358
15.16.2 PRODUCT PORTFOLIO 358
15.16.3 RECENT DEVELOPMENT 358
16 QUESTIONNAIRE 359
17 RELATED REPORTS 368